Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Datopotamab Deruxtecan Earns New Breast Cancer Indication
2.
Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.
3.
Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.
4.
The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.
5.
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma
1.
Engineered Red Blood Cell Therapeutics: Emerging Applications
2.
A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia
3.
AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined
4.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
5.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation